It is also evaluating SL-172154 in an ongoing Phase I clinical trial for the treatment of patients with certain hematologic malignancies, including acute myeloid leukemia (AML), and higher-risk myelodysplastic syndromes (HR-MDS).

Source: https://www.marketscreener.com/quote/stock/SHATTUCK-LABS-INC-113534508/news/Shattuck-Labs-Announces-50-Million-Public-Offering-of-Common-Stock-and-Concurrent-Private-Placement-45617405/?utm_medium=RSS&utm_content=20231221

MABALACAT CITY – Agents of Philippine Drug Enforcement Agency Region III (PDEA-3) cornered nine drug suspects inside a makeshift drug den during a buy-bust operation in Phase I, Barangay Dapdap on Sunday, Feb. 26.

Source: https://mb.com.ph/2023/02/26/nine-drug-suspects-nabbed-inside-drug-den-dismantled-in-mabalacat/?utm_source=rss&utm_medium=rss&utm_campaign=nine-drug-suspects-nabbed-inside-drug-den-dismantled-in-mabalacat

Ms. Varkonda went on to say that the Trustees had not adequately communicated the status of Phase II to the town and had taken undue credit for the success of Phase I in their communication with the lawmakers.

Source: https://vineyardgazette.com/news/2023/01/04/edgartown-and-trustees-spar-over-beach-nourishment-plan

Of course, fianlimab, the LAG-3 antibody, is another important oncology opportunity for us, but we're studying in melanoma, where we have Phase I data that has been confirmed with 2 cohorts.

Source: https://seekingalpha.com/article/4604196-regeneron-pharmaceuticals-inc-regn-bank-of-america-global-healthcare-conference-call?source=feed_all_articles

“Phase I is the environmental and engineering study.

Source: https://www.kjan.com/index.php/2023/11/preferred-design-for-new-i-80-bridge-over-mississippi-river-to-be-revealed/

Prime Minister Narendra Modi had, on December 11, 2022, inaugurated the ‘Hindu HridaySamrat Balasaheb Thackeray Maharashtra Samruddhi Mahamarg’ Phase I, running 520 km from Nagpur to Nashik.

Source: https://www.canindia.com/no-halts-mumbai-nagpur-expressway-becomes-a-killer-with-95-deaths-in-5-months/

We have also completed enrollment in our Phase I multi-center safety trial evaluating glucose control in subjects with Type II diabetes over 12 weeks of treatment.

Source: https://seekingalpha.com/article/4582972-altimmune-alt-q4-2022-earnings-call-transcript?source=feed_all_articles